Physician profile
John Hahn
NPI 1255713772
$18,050.54
in general payments reported to CMS, 2019-2025
31 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.42 · 2020: $8,758 · 2021: $884 · 2022: $5,069 · 2023: $1,532 · 2024: $1,042 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,409 · Travel and Lodging: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,409.44 |
| Travel and Lodging | $836.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,208.35 | 2020-2025 | Da Vinci Surgical System |
| Globus Medical, INC. | $1,724.45 | 2022-2023 | Mars Anterior Retractor |
| Stryker Corporation | $1,317.41 | 2022-2023 | Spy-Phi System, 1688 |
| Medical Device Business Services, INC. | $1,241.48 | 2022 | |
| Davol INC. | $1,151.17 | 2020-2024 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $1,076.06 | 2020-2023 | Gore Bio-A Tissue Reinforcement |
| Ethicon US, LLC | $417.19 | 2022-2024 | Echelon Flex, Enseal X1 |
| Baxter Healthcare | $126.90 | 2019-2020 | |
| Tela Bio, INC. | $120.20 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Sanara Medtech INC. | $74.52 | 2023 | Celleraterx |
| Zimvie INC. | $47.41 | 2022-2023 | |
| Tactile Systems Technology INC | $46.75 | 2020 | |
| Si-Bone, INC. | $46.07 | 2021-2024 | |
| Kerecis Limited | $45.52 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kci USA, INC. | $41.54 | 2022-2023 | V.A.C. Veraflo |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $38.48 | 2024-2025 | Prevena, V.A.C.Instill, Promogran Prisma |
| Takeda Pharmaceuticals U.S.A., INC. | $36.75 | 2023-2025 | Gattex |
| Medtronic, INC. | $34.68 | 2022-2024 | Endoflip |
| Regeneron Healthcare Solutions, INC. | $28.53 | 2023 | Libtayo |
| Abbott Laboratories | $27.24 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $26.53 | 2025 | |
| Merck Sharp & Dohme LLC | $19.66 | 2022 | |
| Phathom Pharmaceuticals, INC. | $18.87 | 2025 | Voquezna |
| Mallinckrodt Hospital Products INC. | $18.12 | 2021 | |
| Merit Medical Systems INC | $18.05 | 2021 | |
| Radius Health, INC. | $17.67 | 2023 | Tymlos |
| Genzyme Corporation | $17.44 | 2022 | |
| Vericel Corporation | $17.17 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.87 | 2022 | |
| Integra Lifesciences Corporation | $15.27 | 2021 | |
| Orthofix Medical, INC. | $15.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.